NHS England has recommended that patients with von Willebrand disease (VWD) be treated with Takeda’s Veyvondi, making it the first and only medicine backed for what is the most common inherited ...
“The approval in Europe for Veyvondi marks a key milestone in our efforts to tackle unmet medical needs for those living with von Willebrand disease. “We are excited to take the next steps in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback